Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies.
Publication/Presentation Date
5-1-2020
Abstract
Hepatitis E virus (HEV), of the family Herpesviridae, is a virus that infects nearly 20 million people per year throughout the world. HEV is most commonly transmitted via the fecal-oral route and has long been described as a virus that afflicts only those in resource-poor countries. However, HEV has been detected in numerous animal carriers, various food sources, and even in human blood products in resource-rich regions of the world. HEV is of importance in the transplant patient population because of its ability to cause chronic viral infection in these patients can lead to graft loss and cirrhosis. In this review, we discuss the current knowledge of HEV as it pertains to the liver transplant patient population and discuss diagnosis and treatment of this infection.
Volume
26
Issue
5
First Page
709
Last Page
717
ISSN
1527-6473
Published In/Presented At
Whitsett, M., Feldman, D. M., & Jacobson, I. (2020). Hepatitis E Virus Infection in the United States: Current Understanding of the Prevalence and Significance in the Liver Transplant Patient Population and Proposed Diagnostic and Treatment Strategies. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 26(5), 709–717. https://doi.org/10.1002/lt.25732
Disciplines
Medicine and Health Sciences
PubMedID
32061053
Department(s)
Department of Medicine
Document Type
Article